Scientists Identify Protein That Spurs Formation of Alzheimer's Plaques
Wednesday, September 1, 2010 - 13:56
in Health & Medicine
Scientists have discovered how the cancer drug Gleevec attacks beta-amyloid, the primary component of senile plaques in Alzheimer's disease. The finding suggests that drugs modeled on Gleevec could provide new treatments for this disease.